Scientific and Medical Equipment House
SAR 26.00-SAR 0.16 (-0.61%)
Scientific and Medical Equipment House’s quoted price sits in the lower half of its reported 52-week range, 34.34% below the high.
SAU · 9527.SR · SAR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 12:10 PM UTC. Cached market data; not a live quote.
One-year closing-price history · SAR. Historical prices are not a forecast.
Alf Meem Yaa for Medical Supplies and Equipment Company’s quoted price sits in the lower half of its reported 52-week range, 39.7% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Alf Meem Yaa for Medical Supplies and Equipment Company’s forward annual dividend is SAR 2.00 per share, paid annual. The forward yield is 2.86% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Alf Meem Yaa for Medical Supplies and Equipment Company’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Ame Company For Medical Supplies operates as a distributor and marketer of medical products specifically designed for the aesthetic market throughout Saudi Arabia. Its comprehensive product catalog features a variety of key offerings, including Teoxane, a line of injectable hyaluronic acid-based dermal fillers formulated to reduce wrinkles on the face and neck. The company also provides advanced medical laser systems, innovative therapeutic solutions, and various botulinum products. Furthermore, their portfolio encompasses Magellan, an autologous concentration system for delivering focused platelets and cells at the point of care, as well as MINT, an absorbable polydioxanone barbed suture used for soft tissue approximation. Established in 2005, the firm is headquartered in Jeddah, Saudi Arabia.
Latest available per-share figures in SAR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:38 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SAR 26.00-SAR 0.16 (-0.61%)
Scientific and Medical Equipment House’s quoted price sits in the lower half of its reported 52-week range, 34.34% below the high.
SAR 22.00+SAR 0.02 (+0.09%)
Naba Alsaha Medical Services Company’s quoted price sits in the lower half of its reported 52-week range, 28.92% below the high.
SAR 17.50SAR 0.00 (0.0%)
Arabian International Healthcare Holding Company’s quoted price sits in the lower half of its reported 52-week range, 36.41% below the high.
SAR 8.23+SAR 0.23 (+2.88%)
Twareat Medical Care Co.’s quoted price sits in the lower half of its reported 52-week range, 50.12% below the high.
SAR 4.27-SAR 0.10 (-2.29%)
Canadian General Medical Center Complex Company’s quoted price sits in the lower half of its reported 52-week range, 52.82% below the high.
SAR 80.60+SAR 0.10 (+0.12%)
Professional Medical Expertise Co.’s quoted price sits in the lower half of its reported 52-week range, 24.67% below the high.
SAR 29.80-SAR 2.20 (-6.88%)
Qomel Company Limited’s quoted price sits in the lower half of its reported 52-week range, 53.44% below the high.
SAR 20.99SAR 0.00 (0.0%)
Almujtama Alraida Medical Co.’s quoted price sits in the lower half of its reported 52-week range, 33.37% below the high.